Assertio Provides Educational Grant for New Lennox-Gastaut Syndrome (LGS) Foundation Treatments Kits
April 24, 2023 09:00 ET
|
Assertio Holdings, Inc.
SYMPAZAN (clobazam) oral CIV film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older Oral film delivery from SYMPAZAN® delivers...
Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) Foundation
January 17, 2023 09:00 ET
|
Assertio Holdings, Inc.
SYMPAZAN® (clobazam) oral film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and olderOral film delivery from SYMPAZAN® delivers...
Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer
June 01, 2022 08:30 ET
|
Longboard Pharmaceuticals, Inc.
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for...
Latvia contracts with Tetra Tech for Innovative Airspace Concept Development and Implementation
March 02, 2016 09:15 ET
|
Tetra Tech
ARLINGTON, Va., March 2, 2016 (GLOBE NEWSWIRE) -- Latvia's Air Navigation Service Provider "Latvijas gaisa satiksme" (LGS), which provides Air Navigation Services in the Riga flight region, has...